Cargando…
Cell-Mediated Therapies to Facilitate Operational Tolerance in Liver Transplantation
Cell therapies using immune cells or non-parenchymal cells of the liver have emerged as potential treatments to facilitate immunosuppression withdrawal and to induce operational tolerance in liver transplant (LT) recipients. Recent pre-clinical and clinical trials of cellular therapies including reg...
Autores principales: | Ellias, Samia D., Larson, Ellen L., Taner, Timucin, Nyberg, Scott L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069094/ https://www.ncbi.nlm.nih.gov/pubmed/33924646 http://dx.doi.org/10.3390/ijms22084016 |
Ejemplares similares
-
Revisiting the liver’s role in transplant alloimmunity
por: Abrol, Nitin, et al.
Publicado: (2019) -
Significance of progressive liver fibrosis in pediatric liver transplants: A review of current evidence
por: George, Mathew, et al.
Publicado: (2020) -
SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19
por: Heimbach, Julie K, et al.
Publicado: (2020) -
Re-Endothelialization of Decellularized Liver Scaffolds: A Step for Bioengineered Liver Transplantation
por: Li, Kewei, et al.
Publicado: (2022) -
Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg
por: DuBrock, Hilary M., et al.
Publicado: (2020)